Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Bangkok Dusit Medical Services Public Company Limited (BDMS) functions as a prominent healthcare conglomerate, with its subsidiaries primarily engaged in operating and owning hospitals. The company oversees a portfolio of six major hospital networks, specifically the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. Beyond providing extensive medical treatment, BDMS also offers holistic clinical wellness programs. Its diversified business interests extend to hospitality, managing hotels and restaurants, as well as retailing health and beauty products. The company provides a broad spectrum of specialized services, including laboratory testing, advanced genome sequencing, skin and aesthetic telemedicine, and air medical transportation. Additionally, BDMS delivers business-centric services such as accounting, investment management, information technology, training, various insurance solutions (including health insurance and brokerage), and property and asset management. Its operations further encompass pharmaceutical manufacturing and distribution, e-commerce, and real estate ventures. BDMS maintains a significant presence with 47 hospitals operating across Thailand and Cambodia. The company was established in 1969 and is headquartered in Bangkok, Thailand.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E
Target Price
The average target price of BDMS.BK is 23.3 and suggests 23.2% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i